Concepedia

Jaclyn N. Highland

JN

Statistics

Publications

8

Citations

627

H-Index

8

Active since

2017

Affiliations

University of Maryland, Baltimore(Current)

National Institute on Aging

National Institutes of Health

VA Maryland Health Care System

National Institute of Mental Health

Jaclyn N. Highland is an author at University of Maryland, Baltimore specializing in medicine, neuropharmacology, and social sciences.

ORCID

Top concepts

Publications per year

2017–2022

8

Publications

8

( <i>2R,6R</i> )-hydroxynorketamine exerts mGlu <sub>2</sub> receptor-dependent antidepressant actions

Panos Zanos, Jaclyn N. Highland, Brent W. Stewart et al. · Proceedings of the National Academy of Sciences · 2019 · 147 citations · Full text

Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor

Polymnia Georgiou, Panos Zanos, Ta-Chung M. Mou et al. · Nature Neuroscience · 2022 · 127 citations · Full text

, , +10

A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice

Panos Zanos, Mackenzie E. Nelson, Jaclyn N. Highland et al. · eNeuro · 2017 · 107 citations · Full text

(<i>R</i>)‐Ketamine exerts antidepressant actions partly via conversion to (<i>2R,6R</i>)‐hydroxynorketamine, while causing adverse effects at sub‐anaesthetic doses

Panos Zanos, Jaclyn N. Highland, Xin Liu et al. · British Journal of Pharmacology · 2019 · 81 citations · Full text

Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (<i>2R,6R</i>)-hydroxynorketamine

Jaclyn N. Highland, Patrick J. Morris, Panos Zanos et al. · Journal of Psychopharmacology · 2018 · 58 citations · Full text

1–5 of 8